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Zinc Cream and 
Reliability of 
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Skin Testing
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Jose Delgado‡ Giselle Soto,‡ Jon S. Friedland,* 
A. Roderick Escombe,*‡ Robert E. Black,¶ 
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In 50 healthy Peruvian shantytown residents, zinc 
cream applied to tuberculosis skin-test sites caused a 32% 
increase in induration compared with placebo cream. Per-
sons with lower plasma zinc had smaller skin-test reactions 
and greater augmentation with zinc cream. Zinc deﬁ  ciency 
caused false-negative skin-test results, and topical zinc 
supplementation augmented antimycobacterial immune re-
sponses enough to improve diagnosis. 
T
uberculosis (TB) kills >1.7 million people each year, 
and control is hampered by diagnostic difﬁ  culties. The 
TB (Mantoux) skin test measures the immune response to 
an intradermal injection of tuberculin (puriﬁ  ed protein de-
rivative [PPD]) and is important for diagnosing adult and 
particularly pediatric TB (1). However, reliability of this 
skin test is limited by false-negative results (2–4), espe-
cially in poorly nourished people in the resource-limited 
settings where most cases of TB occur (2). Zinc is impli-
cated in false-negative skin tests because it modulates cu-
taneous reactions (2,3), because zinc deﬁ  ciency is common 
in people with TB (5), and because this deﬁ  ciency also 
suppresses antimycobacterial immunity (4,5). We there-
fore studied whether topical application of zinc to TB skin 
test sites would augment test results in Lima, Peru, a TB-
endemic area in which false-negative skin-test results are 
frequent (1).
The Study
After ethical approval and informed written con-
sent were obtained, venous blood was collected from 50 
healthy, randomly selected, adult shantytown resident vol-
unteers. Plasma zinc concentrations were analyzed blindly 
by atomic absorption spectroscopy; precautions were taken 
against trace-metal contamination. In each study partici-
pant, the volar surface of both forearms was injected proxi-
mally with tuberculin (5 U in 0.1 mL; Aventis-Pasteur, To-
ronto, Canada) and distally with Candida albicans antigen 
(5 U; Hollister Stier Laboratories, Spokane, WA, USA) (1), 
totaling 4 simultaneous skin tests per person. Candida skin 
tests were conducted because, when positive, they conﬁ  rm 
that the person can mount a cutaneous hypersensitivity 
reaction, which clariﬁ  es that a simultaneous negative TB 
skin-test result is likely to be a true negative.
In a randomized double-blind manner, skin-test sites 
on 1 arm were covered with 1 mL of placebo cream (Aque-
ous cream BP, Sandoz, Bordon, Hants, UK) and the skin-
test sites on the contralateral arm were covered with zinc 
sulfate (2) dissolved in aqueous cream to a concentration 
of 1% elemental zinc. Each skin test site was immediately 
covered with an occlusive dressing (Tegaderm, 3M, Lon-
don, UK). After 24, 48, and 72 h, the dressing and cream 
were removed, and the “ball-point-pen” test was used to 
measure induration. The appropriate cream was reapplied 
and covered after each measurement.
SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) was 
used for statistical analysis. Except where otherwise stated, 
the results of skin tests are those read after 48 h. Continuous 
data were all normally distributed (except for food frequen-
cies) and were therefore summarized as means (and stan-
dard errors of the mean [SEM]). Groups were compared by 
using t tests, and associations were tested by using univari-
ate linear regression (p value and standardized coefﬁ  cient 
shown) and in a backward multiple linear regression model 
with the least signiﬁ  cant variables sequentially removed, 
according to the log-likelihood test.
Conclusions
Control TB skin-test areas to which placebo cream had 
been applied yielded signiﬁ  cantly smaller reactions in per-
sons with lower concentrations of plasma zinc (p = 0.03, 
Table). For example, the quarter of the population with the 
lowest concentrations had, on average, control TB skin-test 
reactions that were 14 mm in diameter compared with 27 
mm for the quarter of the population with the highest plas-
ma zinc concentrations (p = 0.03). This immunologically 
signiﬁ  cant zinc deﬁ  ciency was frequent even though only 
10% of the study population was underweight (body mass 
index <20 m2/kg).
The TB skin-test results were read in a blinded manner, 
and reactions to tests with zinc cream applications were an 
average of 32% larger than the contralateral control skin test 
reactions with placebo cream applied (Figure 1; p<0.001). 
TB skin-test results were considered positive if the average 
diameter of induration was >10 mm 48 h after injection, 
according to national policy. Skin tests with zinc applica-
tions were signiﬁ  cantly more likely to have positive results 
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than the simultaneous contralateral control skin tests with 
placebo cream applications (94% zinc vs. 76% placebo, p 
= 0.01). Topical zinc caused greater TB skin-test augmen-
tation in persons with lower plasma zinc concentrations 
(correlation coefﬁ  cient [R] = 0.3, p = 0.05), and persons 
with absolute plasma zinc deﬁ  ciency (<0.6 mg/L) had sig-
niﬁ  cantly greater zinc-mediated augmentation (Figure 2, p 
= 0.02). Zinc cream had no effect in persons with normal 
plasma zinc concentrations. Thus, zinc cream signiﬁ  cantly 
augmented TB skin-test reactions only in persons deﬁ  cient 
in zinc (Figure 2).
TB skin tests are usually read 48 h after PPD injection; 
however, in this study, additional readings were done at 
24 and 72 h, at which time results, similar to those at 48 
h, demonstrated that zinc cream caused larger TB skin-test 
reactions (both p<0.02) and more positive test results (both 
p<0.006). Furthermore, at 72 and 48 h, this zinc-mediated 
augmentation was greater in zinc-deﬁ  cient persons (p = 
0.006), although the similar trend at 24 h was not statisti-
cally signiﬁ  cant. The magnitude of skin-test augmentation 
with zinc cream, the plasma zinc concentration, and the an-
thropometric measures had no signiﬁ  cant associations with 
other studied factors except as noted in the Table.
The effect of zinc on the Candida skin-test results 
was similar to the effect on the TB skin-test results. Spe-
ciﬁ  cally, the Candida skin-test reactions with zinc cream 
were an average of 23% larger than the contralateral skin-
test reactions associated with placebo cream applied in a 
double-blind manner (p<0.001). Candida skin-test results 
were considered positive if the average diameter of indura-
tion was >5 mm (1), and 78% of Candida skin-test results 
associated with zinc application were positive, compared 
with 64% with placebo cream (p = 0.01). Zinc-mediated 
TB and Candida skin-test augmentation were associated (R 
= 0.3, p = 0.05), but zinc-mediated Candida skin-test aug-
mentation was not signiﬁ  cantly associated with any of the 
variables in the Table.
The control skin tests with placebo cream yielded larg-
er reactions (p = 0.005) and were more likely to be positive 
(p = 0.005) than concurrent skin tests on 97 other randomly 
Table. Population characteristics for the participants who had simultaneous skin tests with and without zinc and associations with size 
of tuberculosis (TB) skin-test reaction 
Association with size of control TB skin-test reaction (mm)
Univariate analysis Multiple regression
Characteristic*
Mean (SEM)† or % 
(n = 50) Coefficient p Coefficient p
Nutritional assessment‡§
  Body mass index (kg/m
2) 24 (0.52) 
10% underweight (<20)
0.2 0.3
  Anthropometric protein status 
  (corrected arm muscle area; cm
2)
36 (1.4) 0.2 0.09
  Anthropometric fat status 
  (arm fat area; cm
2)
14 (1.1) 0.0008 1
  Plasma zinc (mg/L; n = 49) 0.66 (0.17) 
31% deficient (<0.6)
0.3 0.04 0.3 0.03
Minor incidental health symptoms 38% 0.06 0.7
TB risk factors
 Age,  y 32  (1.3) 0.2 0.2 0.3 0.02
 Male  38% 0.3 0.03 0.4 0.01
  Past close contact with a TB patient or  
  past proven diagnosis of TB 
42% 0.1 0.4
  Presence of Baccilus Calmette-Guérin  
 vaccine  scar(s)
86% 0.2 0.3
 Overcrowding  (persons/room) 1.3  (0.08) –0.2 0.9 0.2 0.09
 Poor  household  ventilation  (subjective 
 assessment)
24% –0.002 1
Socioeconomic status
  Food spending/person/d ($US) 0.75 (0.05) 0.1 0.5
  Dirt floor throughout the home 38% –0.06 0.7
  Home built from temporary materials 72% 0.1 0.5
 No  in-house  sanitation 84% 0.05 0.7
  No piped water to home 84% –0.07 0.6
*Variables that may influence TB skin-test reaction size are shown together with their associations with the size of the control TB skin-test reactions 
associated with only zinc cream application. 
†SEM, standard error of the mean. 
‡Food frequencies: in the previous week, alcohol had been consumed a median of 1 time (median 1 U), dairy produce 3 times, fruit/vegetables 5 times, 
meat/fish 6 times, and rice/bread/cereals daily. 
§Persons with infrequent meat/fish consumption had lower protein stores on muscle anthropometry (p = 0.02), and this tended to be associated with 
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selected healthy volunteers in the same community (data 
not shown). These 97 skin tests were each performed on 1 
arm only, and no creams were applied; the mean diameter 
of induration was 16.4 mm (SEM 1.9 mm), and 52% were 
TB skin-test positive (>10 mm). Although the design of this 
part of the study prevented blinded assessment, this com-
parison implies that in the 50 persons with simultaneous 
bilateral skin tests, zinc absorption through the skin may 
have partially augmented the contralateral control skin-test 
reactions to which placebo cream was applied. Although 
the local direct effect at the site of zinc cream application 
was signiﬁ   cantly greater, systemic zinc absorption may 
have caused the effect of zinc cream to be underestimated; 
this hypothesis is being further investigated.
Zinc status is difﬁ  cult to reliably assess (2–4). How-
ever, low plasma zinc signiﬁ  cantly predicted small skin-
test reactions and the magnitude of the immunologic re-
sponse to topical supplementation. Thus, zinc cream had a 
speciﬁ  c effect, namely, reversing the skin-test suppression 
of zinc deﬁ  ciency. Topical zinc supplementation applied 
to the arms of persons who received TB skin tests there-
fore identiﬁ  ed persons in whom zinc deﬁ  ciency was sufﬁ  -
cient to suppress antimycobacterial immune responses and 
quantiﬁ  ed the immune-potentiating effect of supplementa-
tion. This approach may similarly facilitate the therapeutic 
evaluation of other micronutrients and immunomodulatory 
compounds.
Zinc cream had no effect in persons with adequate con-
centrations of zinc; however, persons who were deﬁ  cient in 
zinc but otherwise apparently healthy had suppressed skin-
test reactions, despite the absence of frank malnutrition; this 
suppression was reversed by the application of zinc cream. 
Thus, zinc cream application corrected false-negative TB 
skin-test reactions caused by zinc deﬁ  ciency, allowed more 
sensitive diagnosis, and hence facilitated appropriate treat-
ment of latent TB infection. Topical zinc is a simple and 
relatively inexpensive method of enhancing reliability of 
the established TB skin test for diagnosing this neglected 
disease. This has public health implications because the TB 
skin test is central to the problematic area of diagnosing 
TB infection and disease, especially in children who are 
prone to both zinc deﬁ  ciency (2,4) and false-negative skin-
test results (1). Therefore, the zinc-mediated augmentation 
of TB skin testing that we have demonstrated may facilitate 
the diagnosis of adult and pediatric cases of TB in regions 
where micronutrient deﬁ  ciency is prevalent. 
In conclusion, this study demonstrated that physiologi-
cally signiﬁ  cant subclinical zinc deﬁ  ciency was common 
in this population, that low plasma zinc predicted negative 
TB skin-test results, and that topical zinc supplementation 
augmented local antimycobacterial immune responses suf-
ﬁ  ciently to reverse this anergy of micronutrient deﬁ  ciency.
Figure 1. Effect of topical zinc on size of tuberculosis (TB) skin-
test reaction. Each line represents the size of the 2 TB skin-test 
reactions for 1 person with placebo cream (on the left of the graph) 
and topical zinc cream (on the right). Circles show the mean TB 
skin-test reaction size without and with topical zinc, with standard 
error bars.
Figure 2. Association between plasma zinc concentration and 
response to topical zinc. The association is shown between plasma 
zinc concentration and the magnitude of augmentation of the 
puriﬁ  ed protein derivative skin test with topical zinc. The normal 
range of plasma zinc (>0.6 mg/L) is also indicated.DISPATCHES
1104  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 7, July 2007
Acknowledgments
We thank the volunteers of Susana Higushi community, who 
generously gave written informed consent to have paired skin 
tests for medical research; Tom Doherty, Barbara Golden, and 
Mayuko Saito for helpful discussions; and Katherine Sacksteder 
for editorial assistance.
C.A.E. and A.R.E. are funded by the Wellcome Trust. C.A.E. 
and this research were funded in part by the charity Innovation for 
Health and Development. V.B.R. was funded by the Special Trust-
ees of the Hospital for Tropical Diseases. 
Dr Rao is a physician specializing in international public 
health practice and research.
References
  1.   Pelly TF, Santillan CF, Gilman RH, Cabrera LZ, Garcia E, Vidal C, 
et al. Tuberculosis skin testing, anergy and protein malnutrition in 
Peru. Int J Tuberc Lung Dis. 2005;9:977–84.
  2.   Golden MH, Harland PS, Golden BE, Jackson AA. Zinc and im-
munocompetence in protein-energy malnutrition. Lancet. 1978;1: 
1226–8.
  3.   Lin RY, Busher J, Bogden GJ, Schwartz RA. Topical zinc sulfate 
augmentation of human delayed type skin test response. Acta Derm 
Venereol. 1985;65:190–3.
  4.   Cuevas LE, Almeida LM, Mazunder P, Paixao AC, Silva AM, Ma-
ciel L, et al. Effect of zinc on the tuberculin response of children ex-
posed to adults with smear-positive tuberculosis. Ann Trop Paediatr. 
2002;22:313–9.
  5.   Karyadi E, West CE, Schultink W, Nelwan RH, Gross R, Amin Z, 
et al. A double-blind, placebo-controlled study of vitamin A and 
zinc supplementation in persons with tuberculosis in Indonesia: 
effects on clinical response and nutritional status. Am J Clin Nutr. 
2002;75:720–7.
Address for correspondence: Carlton A. Evans, Asociacion Beneﬁ  ca 
Prisma, Av Carlos Gonzales Nro. 251, Urb. Maranga, San Miguel, Lima 
32, Peru; email: carltonevans@yahoo.com
Use of trade names is for identiﬁ  cation only and does not imply 
endorsement by the Public Health Service or by the U.S. 
Department of Health and Human Services.
Search 
past Issues